← Eichor
Condition: Growth Disorders Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Growth Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

BALANCED GROWTH: The Involvement of the Vestibular System in a Child's Cognitive and Motor Development
Phase N/A · 1 location(s) · University Ghent · NCT04685746Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04645160Early Childhood Obesity Programming by Intrauterine Growth Restriction
Phase N/A · 1 location(s) · Montefiore Medical Center · NCT03402139Bioimpedence and Arterial Function Monitoring at Birth and in Infants
Phase N/A · 2 location(s) · Imperial College Healthcare NHS Trust · NCT04720690A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.
Phase N/A · 4 location(s) · Pfizer · NCT06587035KETOgenic Diet Therapy in Patients With ACROmegaly
NA · 1 location(s) · Erasmus Medical Center · NCT06949891DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Tre
Phase 3 · 250 location(s) · AstraZeneca · NCT06989112Study the Effect of Upper Expansion Appliances on Lower Jaw Forward Projection/Growth
NA · 1 location(s) · University of Alberta · NCT03286569Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer
Phase N/A · 1 location(s) · Julia Foldi · NCT06666439Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan
Phase 2 · 1 location(s) · Aga Khan University · NCT07207434Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Canc
Phase 1/Phase 2 · 1 location(s) · Guangzhou Medical University · NCT06462092Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
Phase N/A · 1 location(s) · LG Chem · NCT01604395An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
Phase 3 · 77 location(s) · Dompé Farmaceutici S.p.A · NCT07519902ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
Phase 2 · 45 location(s) · Alexion Pharmaceuticals, Inc. · NCT07037420Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Phase 3 · 181 location(s) · AbbVie · NCT05407636Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children
Phase 3 · 30 location(s) · Materia Medica Holding · NCT07171099Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT04752293Natural History of Craniofacial Anomalies and Developmental Growth Variants
Phase N/A · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT02639312A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With An
Phase 1/Phase 2 · 68 location(s) · BioNTech SE · NCT06827236The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06830551Multicenter Trial of Proximal Femoral Guided Growth in Children With CP and Hips at Risk of Dislocation (GGSH-MC)
NA · 16 location(s) · Fundación para la investigación biomética Hospital Infantil · NCT06956729The BEGIN Study Bifidobacterium Infantis to Newborns: Effects of Modulating the Gut Microbial Composition on Growth, Imm
NA · 2 location(s) · University of Aarhus · NCT06452199Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT
NA · 1 location(s) · Prince of Songkla University · NCT03648814Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficien
Phase 3 · 16 location(s) · VA Office of Research and Development · NCT04867317A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Ute
Phase 3 · 171 location(s) · BioNTech SE · NCT06340568Human Microbiome Research and Development for Overcoming Pediatric Diseases
Phase N/A · 1 location(s) · Hanyang University · NCT06812091Evaluation of the Propensity of Patients Under rhGH to Envision a Modification of Their Treatment Regimen Toward LAGH
NA · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT06542809A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC
Phase 2 · 1 location(s) · Sichuan University · NCT06951464A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
Phase 1/Phase 2 · 2 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06202261Boosting Osimertinib Blood Brain Barrier Penetration
Phase 2 · 2 location(s) · Maastricht University Medical Center · NCT07485452
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.